Biology Means Business: A Bioeconomic Wave
Biology is fast becoming a defining platform for industrial innovation. Long associated with pharmaceuticals and agriculture, the tools and techniques of biotechnology are now being applied across a wide range of sectors—from materials and packaging to energy and consumer goods. What’s emerging is a new phase of economic transformation: one where living systems, natural processes, and engineered biology are unlocking new forms of value. And it’s happening because biology offers better performance, lower emissions, and, increasingly, lower costs. As businesses face pressure to innovate sustainably and build more resilient supply chains, the bioeconomy is becoming a strategic growth driver.
In fact, researchers estimate that bio-based innovations could eventually affect up to 60% of the world’s physical inputs, enabling sustainable production of everything from bioplastics to fuels. Even partial realization of this potential would reshape economies and societies—changing what we eat and wear, how we build, and the medicines we take. A pipeline of approximately 400 biologically-driven use cases could generate up to $4 trillion in annual economic impact within the next 10–20 years, and more than half of this lies outside healthcare—in materials, consumer goods, agriculture, and energy.
From Code to Cell
Just as the digital revolution defined the last generation of business transformation, biology is becoming the technological substrate of the next. Tools like CRISPR and breakthroughs in DNA sequencing, synthetic biology, and automation have radically lowered the barriers to biological R&D. Sequencing costs have fallen even faster than Moore’s Law, unlocking vast biological datasets. Further, machine learning is now optimizing biological discovery in ways similar to what it has done for software and systems engineering.
Companies are increasingly designing biological solutions with precision. Engineered microbes can now produce flavors, fragrances, food proteins, or polymers—replacing traditional chemical manufacturing methods. Biology is becoming an innovation platform for the global economy. This enables businesses to fundamentally rethink inputs, processes, outputs and approach to scale.
As this shift accelerates, the bioeconomy is emerging as a practical and scalable pillar of a sustainable innovation strategy. For companies looking to decarbonize supply chains, differentiate products, or reduce reliance on volatile resource markets, biologically derived solutions offer a path forward—one grounded in science, enabled by technology, and aligned with long-term economic advantage.
Real Products, Real Markets
While some vectors in sustainable innovation have suffered from a speculation, this isn’t the case in the bioeconomy, with pathways and impacts showing up across a variety of sectors and verticals.
Materials & Foods: Synthetic biology firms like Ginkgo Bioworks and Checkerspot use engineered microbes to ferment industrial ingredients for materials and foods.
Fashion: Japanese firm Spiber is brewing spider silk-inspired fibers through fermentation. Their “Brewed Protein™” has appeared in numerous clothing and fabric applications.
Packaging: Notpla creates seaweed-based films and takeaway boxes that biodegrade naturally. Ecovative grows mycelium-based solutions with packaging adopted by IKEA and Dell.
Construction: Made of Air transforms forest and agricultural waste into carbon-negative components for composites.
Crucially, these aren’t PR stunts—they’re live and evolving commercial efforts, often delivering differentiated performance and growing market acceptance with major commercial partners. The global bioplastics market alone is projected to reach $44+ billion with other estimates going even higher.
Designing for Resilience, Growth, and Advantage
The bioeconomic approach offers more than just small ‘s’ sustainability—it provides strategic value in three ways.
1. Resilience and Risk Management
Biological inputs and systems tend to be renewable, distributed, and often waste-fed. That makes them more resilient than many extractive systems. Fermentation-based ingredients, for example, are insulated from oil price volatility. Drought-resistant bioengineered crops reduce exposure to climate disruption. Companies aligning with circular and regenerative biological processes are often better positioned to withstand shocks and supply chain volatility.
2. Innovation and Market Expansion
New biological capabilities are giving rise to entire industries. For example, fermented proteins could reach 4% of the global protein market by 2050—a $100–150 billion segment. Cosmetics companies are replacing rare or unsustainable ingredients with fermented or bio-extracted alternatives. Further, in the medium to long view, there’s significant business upside lying not just in substituting inputs but in unlocking new product categories like carbon-negative materials or compostable product schemes.
3. Alignment with Stakeholders and Regulation
Biology-driven solutions increasingly align with policy shifts (e.g., plastic bans, carbon labeling) and stakeholder expectations on climate and sustainability. Nature-derived materials often confer marketing benefits, reduced regulatory exposure, and easier compliance with emerging sustainability standards.
A recent study estimates that “nature-positive” strategies—including bio-based innovation—could unlock $10 trillion in annual business value and 395 million jobs by 2030. This approach could be central to 21st-century economic growth.
This Is the Moment
What digital was to the last era, biology is to this one. The companies embracing this shift are finding measurable gains in product performance, brand strength, and market entry. Not every biological innovation will scale; there are cost, technical, and infrastructure hurdles to overcome. Yet, the trajectory is evident.
A growing number of major enterprises are treating bio-based innovation as core R&D and strategy, not side bets. Startups are tackling hard problems with new science. Investors are directing billions to synthetic biology and biomaterials. Governments are funding national bioeconomy initiatives. A global transformation of how we make, move, and use things is quietly underway—and a bioeconomic approach to sustainable innovation is at the center of it.act.
Ready for the Bioeconomy?
Tackling the challenges of today and creating the opportunities for tomorrow requires embracing a sustainable innovation program. Partner with us to see how we can advance opportunities in a rapidly changing business landscape.
